THE USE OF PLASMAPHERESIS IN THE TREATMENT OF CORONARY ARTERY DISEASE OF TRANSPLANTED HEART AND EVALUATION OF ITS EFFECTIVENESS
https://doi.org/10.15825/1995-1191-2009-2-25-28
Abstract
The paper presents the experience with plasmapheresis in the treatment of сoronary artery disease with drug therapy. 19 recipients at different time after cardiac transplantation with coronary artery disease confi rmed by angiography were treated by therapeutic plasmapheresis courses. The effectiveness was estimated by radioisotope, immunomorphological and laboratory methods. After the course there were increase of regional and local myocardium contractility, increase in left ventricle ejection fraction, reducing intraventricular asynchrony, permission immunocomplex syndrome and lack of local intravascular blood coagulation. Plasmapheresis is considered as a promising method for the impact on the factors contributing to the accelerated nature of the development of coronary arteries lesions in transplanted heart.
About the Authors
N.Z. MeboniyaRussian Federation
B.N. Morozov
Russian Federation
E.N. Ostroumov
Russian Federation
A.G. Kupriyanova
Russian Federation
N.A. Maksimova
Russian Federation
References
1. Шумаков В.И., Остроумов Е.Н., Сонин С.А. и др. Радионуклидная вентрикулография в оценке функции
2. миокарда левого и правого желудочков пересаженного сердца // Вестник трансплантологии и искусствен-
3. ных органов. 2002. № 32. С. 3–8.
4. Шумаков В.И., Хубутия А.Ш., Белецкая Л.В. Отторжение гуморального типа при аллотрансплантации сердца. М., 2003. С. 108–128.
5. Найдич А.М. Механическая активность миокарда трансплантированного сердца в зависимости от течения болезни коронарных артерий: Автореферат дисс. … к. м. н. М., 2001.
6. Сонин С.А. Радионуклидная вентрикулография в оценке функции миокарда левого и правого желудочков пересаженного сердца: Автореферат дисс. …к. м. н. М., 2001.
7. Болезнь коронарных артерий пересаженного сердца /Под ред. В.И. Шумакова. М., 2008. С. 145–153.
8. Ventura H.O., Mehra M.R., Smart F.W., Stapleton D.D. Cardiac allograft vasculopathy: current concepts // Am Heart J. 1995. V. 129. P. 791–798.
9. Wellnhofer E., Bocksch W., Hiemann N. et al. Remodeling: Study of Cardiac Allograft Coronary Artery Disease as a Model of Diffuse Atherosclerosis // J Heart Lung Transplant. 2002. V. 21. P. 405–416.
10. Crespo-Leiro M.G., Veiga-Barreiro A., Domenech N. et al. Humoral Heart Rejection (Severe Allograft Dysfunction with no Signs of Cellular Rejection or Ischemia): Incidence, Management, and the Value of C4d for Diagnosis // Am J of Transplantation. 2005. V. 5. P. 2560–2564.
11. Grauhan O., Knosalla C., Ewert R. et al. Plasmapheresis and cyclophosphamide in the treatment of humoral rejection
12. after heart transplantation // J Heart Lung Transplant. 2001. V. 20. P. 316–321.
13. Ratkovec R., Hammond E., O’Connell J. et al. Outcome of cardiac transplant recipients woth a positive donorspecifi
14. c crossmatch-preliminary results with plasmapheresis // Transplantation. 1992. V. 54. P. 651–655.
15. Schroeder J.S., Hunt S.A., Stinson E.B. et al. Accelerated graft coronary artery disease: diagnosis and prevention // J heart and Lung Transplant. 1992. V. 11. P. 258–266.
16. Gao Sh. Z., Alderman E.L., Schroeder J.S. et al. Accelerated coronaru vascular disease in the heart transplant patient: coronary arteriographic fi ndings // J Am Coll. Cardiol. 1998. V. 12. P. 334–340.
Review
For citations:
Meboniya N., Morozov B., Ostroumov E., Kupriyanova A., Maksimova N. THE USE OF PLASMAPHERESIS IN THE TREATMENT OF CORONARY ARTERY DISEASE OF TRANSPLANTED HEART AND EVALUATION OF ITS EFFECTIVENESS. Russian Journal of Transplantology and Artificial Organs. 2009;11(2):25-28. (In Russ.) https://doi.org/10.15825/1995-1191-2009-2-25-28